Onat F, Tellioğlu T, Aker R, Gören Z, Iskender E, Oktay S
Department of Pharmacology, Marmara University, School of Medicine, Haydarpaşa, Istanbul, Turkey.
Eur J Pharmacol. 1998 Dec 4;362(2-3):173-81. doi: 10.1016/s0014-2999(98)00754-7.
Brain acetylcholine and gamma-aminobutyric acid (GABA) are both involved in the regulation of central cardiovascular control. Despite data from anatomical and electrophysiological experiments characterizing the interaction between central GABAergic and cholinergic neurotransmission, the potential significance of this interaction in central cardiovascular regulation remains unknown. The purpose of this study was to determine whether activation of GABA(A) receptors by intracerebroventricular or intrahypothalamic administration of muscimol affects the cholinergic agonist-induced cardiovascular responses. All experiments were performed in conscious, Sprague-Dawley rats instrumented with a guide cannula for drug injection and iliac arterial catheters for direct measurement of mean arterial pressure and heart rate. Administration of a cholinergic agonist, carbachol, either intracerebroventricularly or into the dorsomedial hypothalamic nucleus, produced a significant increase in mean arterial pressure, whereas injection of carbachol into the posterior hypothalamic nucleus caused a slight elevation in blood pressure. Pretreatment with muscimol 10 min before administration of carbachol prevented the carbachol-evoked blood pressure changes. On the other hand, carbachol produced variable changes in heart rate, depending on the site of injection. In [3H]quinuclydinyl benzilate binding experiments, muscimol did not displace the muscarinic radioligand from its binding sites, suggesting that it does not exert any direct antagonistic activity at muscarinic receptors. These results suggest that the dorsomedial hypothalamic nucleus is a potential site of action for microinjected carbachol and that the GABAergic system has an inhibitory influence on cholinergic neurons involved in blood pressure regulation.
脑内乙酰胆碱和γ-氨基丁酸(GABA)均参与中枢心血管调控。尽管有来自解剖学和电生理学实验的数据描述了中枢GABA能与胆碱能神经传递之间的相互作用,但这种相互作用在中枢心血管调节中的潜在意义仍不清楚。本研究的目的是确定通过脑室内或下丘脑内注射蝇蕈醇激活GABA(A)受体是否会影响胆碱能激动剂诱导的心血管反应。所有实验均在清醒的Sprague-Dawley大鼠中进行,这些大鼠植入了用于药物注射的引导套管和用于直接测量平均动脉压和心率的髂动脉导管。脑室内或向背内侧下丘脑核注射胆碱能激动剂卡巴胆碱,可使平均动脉压显著升高,而向后下丘脑核注射卡巴胆碱则导致血压略有升高。在注射卡巴胆碱前10分钟用蝇蕈醇预处理可防止卡巴胆碱引起的血压变化。另一方面,卡巴胆碱根据注射部位不同使心率产生不同变化。在[3H]喹核酯结合实验中,蝇蕈醇不会从其结合位点置换毒蕈碱放射性配体,这表明它在毒蕈碱受体上不发挥任何直接拮抗活性。这些结果表明,背内侧下丘脑核是微量注射卡巴胆碱的潜在作用部位,并且GABA能系统对参与血压调节的胆碱能神经元具有抑制作用。